Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

• Main Authors: Junji Furuse (Author), Namiki Izumi (Author), Kenta Motomura (Author), Yoshitaka Inaba (Author), Yoshio Katamura (Author), Yasuteru Kondo (Author), Kazuhisa Yabushita (Author), Katsuaki Motoyoshi (Author), Masatoshi Kudo (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Lenvatinib was approved for use in unresectable hepatocellular carcinoma (uHCC) in Japan in 2018. Patients with diverse clinical characteristics receive lenvatinib treatment in clinical practice. Thus, it is crucial to evaluate the safety and effectiveness of lenvatinib in real-w...